Athenex Stock Price. Everything You Need To Know About The Athenex Stock!
Athenex, Inc. is a biopharmaceutical company headquartered in Buffalo, New York, that specializes in the discovery, development, and commercialization of novel cancer therapies. With 269 full-time employees, the company is dedicated to developing next-generation products for the treatment of cancer, with a focus on its Oncology Innovation Platform and Commercial Platform segments.
The Oncology Innovation Platform is responsible for the research and development of Athenex’s drugs, which are derived from its technologies: Cell Therapy, based on natural killer T (NKT) cells, and Orascovery, based on a P-glycoprotein pump inhibitor. Meanwhile, the Commercial Platform focuses on the sales and marketing of the company’s specialty drugs and the market development of its drugs.
Athenex’s clinical pipeline in the Oncology Innovation Platform includes product candidates such as KUR-501, KUR-502, and KUR-503. KUR-501 is an autologous product that involves engineering NKT cells with a chimeric antigen receptor (CAR) targeting disialoganglioside (GD2). On the other hand, KUR-503 is an allogeneic product that involves engineering NKT cells with a CAR targeting glypican-3.
For investors, it is important to stay informed on the latest developments in the biopharmaceutical industry. By researching Athenex, Inc. and its innovative cancer therapies, investors can gain valuable insights into the company’s offerings and market position. It is also important to keep an eye on trends such as the stocks share price today and premarket activity, to make informed decisions about potential investment opportunities.
As with any investment, it is crucial to conduct thorough research and consult with financial professionals before making any decisions. By staying informed and taking a cautious approach, investors can potentially benefit from the promising developments in the biopharmaceutical industry.
Athenex Stock Price. Everything You Need To Know About The Athenex Stock! performance
- Employees 269
- Company HQ Buffalo
- Website https://www.athenex.com/
- Asset Type
- Market Capitalization 0
- Earnings Per Share
- Dividends Per Share
- Dividend Date
- Quarterly Earnings Growth
Are you interested in investing in the pharmaceutical industry? Look no further than Athenex, a promising stock option for retail investors in Malaysia, Thailand, Indonesia, and Vietnam. As an investment platform, Zorion provides valuable insights and recommendations on this stock to aid you in making informed decisions. Athenex, a leading global biopharmaceutical company, specializes in discovering and developing innovative therapies for cancer treatment. By investing in Athenex, you can participate in the growth of this cutting-edge industry and contribute to advancements in medical science. To invest in Athenex from Malaysia, Thailand, Indonesia, and Vietnam, simply sign up with Zorion, where you’ll have access to a host of resources and educational materials that will enhance your understanding of the stock market and maximize your returns. Start your investment journey today with Athenex and Zorion, your trusted investment partner.
